Role of central histamine in amygdaloid kindled seizures.
-
- KAMEI Chiaki
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Okayama University
-
- OKUMA Chihiro
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Okayama University
Bibliographic Information
- Other Title
-
- 中枢ヒスタミン神経系とへん桃核キンドリング
- 中枢ヒスタミン神経系と扁桃核キンドリング
- チュウスウ ヒスタミン シンケイケイ ト ヘントウカク キンドリング
Search this article
Description
The role of central histamine in amygdaloid kindled seizures in rats was studied. Histamine content in the amygdala was significantly decreased after development of amygdaloid kindling. Intracerebroventricular (i.c.v.) injection of histamine resulted in inhibition of amygdaloid kindled seizures. The H1-agonists 2-methylhistamine and 2-thiazolylethylamine also inhibited amygdaloid kindled seizures. In addition, intraperitoneal (i.p.) injection of histidine and metoprine inhibited amygdaloid kindled seizures at doses that caused increases in histamine contents of the brain. H1-antagonists (diphenhydramine and chlorpheniramine) attenuated histamine- or histidine-induced inhibition of amygdaloid kindled seizures. Both i.c.v. and i.p. injections of H3-antagonists (thioperamide, AQ0145 and clobenpropit) resulted in a dose-related inhibition of amygdaloid kindled seizures. The effects of thioperamide and AQ0145 were inhibited by an H3-agonist (R)-α-methylhistamine and H1-antagonists. On the other hand, H2-antagonists showed no antagonistic effect. GABAmimetic drugs, diazepam, sodium valproate and muscimol potentiated the effect of clobenpropit. Bicuculline caused significant antagonism of the inhibition of amygdaloid kindled seizures induced by clobenpropit. These findings suggested that a histaminergic mechanism plays an important role in suppressing amygdaloid kindled seizures through histamine H1-receptors. In addition, an inhibition of amygdaloid kindled seizures induced by histamine is closely related with the action of GABA.
Journal
-
- Folia Pharmacologica Japonica
-
Folia Pharmacologica Japonica 117 (5), 329-334, 2001
The Japanese Pharmacological Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679250213376
-
- NII Article ID
- 10007366236
-
- NII Book ID
- AN00198335
-
- COI
- 1:CAS:528:DC%2BD3MXjsFGitrg%3D
-
- ISSN
- 13478397
- 00155691
-
- NDL BIB ID
- 5753283
-
- PubMed
- 11411342
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed